Insider filing · HRMY
Jeffrey M. Dayno
PRESIDENT, CEO
profile →
Harmony Biosciences Holdings, Inc.
HRMY · Healthcare · 21 filings in 24 months
ticker →
Jeffrey M. Dayno sold $1.0M of Harmony Biosciences (HRMY)
Executed Dec 12 2025, disclosed Dec 17 2025, 5 days later, against a two-business-day limit.
Value, as filed
$1.0M
25,933 sh across 2 lots
Executed
Dec 12 2025
the trade date, as filed
Disclosed
Dec 17 2025
5 days after the trade · past the deadline
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JDJeffrey M. Dayno (PRESIDENT, CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Harmony Biosciences Holdings, Inc. (HRMY). The largest single filing was $1.0M of HRMY (25,933 sh across 2 lots, as filed), executed Dec 12 2025.
The name
HRMYHealthcare · Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for pati…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeffrey M. Dayno in HRMY
HRMYSALE
Harmony Biosciences Holdings, Inc.
$774K19,293 sh × $40.13
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET